ArticleEJHaem2024

A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practice.

Monica Messina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.